Company

Our team possesses deep, cross-functional experience and shares a longstanding commitment to developing new medicines to benefit cancer patients.

Management


m-rothera-viracta

Mark Rothera

President and Chief Executive Officer

Lisa-Rojkjaer

Lisa Rojkjaer, M.D.

Chief Medical Officer

Dan-Chevallard

Dan Chevallard

Chief Operating Officer and Chief Financial Officer

Ayman

Ayman Elguindy, Ph.D.

Chief Scientific Officer

Stewart-M-Brown

Stewart M. Brown

Senior Vice President, Legal Affairs & General Counsel

Cheryl-Madsen

Cheryl Madsen

Senior Vice President, Regulatory

patric

Patric Nelson, MBA

Senior Vice President, Business Development & Corporate Strategy

violetta-akopian

Violetta Akopian, Ph.D.

Vice President, Quality Assurance

Biljana

Biljana Nadjsombati, Pharm.D.

Vice President, Pharmaceutical Development

Shelly_Vandertie

Shelly Vandertie

Vice President, Finance

Ruby-Cheema

Ruby Cheema

Vice President, Portfolio and Program Management

Strategic Advisor


Mark A. McCamish, M.D., Ph.D.

Strategic Advisor

Board of Directors


Roger J. Pomerantz, M.D.

Chairman of the Board

Jane F. Barlow, M.D., MPH, MBA

Director

Flavia Borellini, Ph.D.

Director

Jane Chung, R.Ph.

Director

Thomas E. Darcy, CPA

Director

Sam Murphy, Ph.D.

Director

Nicole Onetto, M.D.

Director

Mark Rothera

President, Chief Executive Officer and Director

Ivor Royston, M.D.

Director

Stephen Rubino, Ph.D., MBA

Director

Barry J. Simon, M.D.

Director

Scientific Advisory Board


Douglas V. Faller, M.D., Ph.D.

Scientific Founder and Chairman, Scientific Advisory Board

Robert Baiocchi, M.D., Ph.D.

Scientific Advisor

Corey Casper, M.D., MPH

Scientific Advisor

Charles Cobbs, M.D.

Scientific Advisor

Carl June, M.D.

Scientific Advisor

Shannon Kenney, M.D.

Scientific Advisor

Ronald Levy, M.D.

Scientific Advisor

Pierluigi Porcu, M.D.

Scientific Advisor

Daniel D. Von Hoff, M.D., F.A.C.P. FASCO, FAACR

Scientific Advisor

Lawrence Young, Ph.D.

Scientific Advisor